Skip to main content
. 2026 Feb 13;27(4):1790. doi: 10.3390/ijms27041790
AD Alzheimer’s Disease
ANCOVA Analysis of Covariance
AUC Area Under the Curve
AUPRC Area Under the Precision–Recall Curve
AT(N) Amyloid/Tau/Neurodegeneration Framework
42 Amyloid-Beta 42
BIOMARKAPD Biomarkers for Alzheimer’s Disease
CDT Clock Drawing Test
CI Confidence Interval
CPM-47 Raven’s Colored Progressive Matrices (47 items)
CSF Cerebrospinal Fluid
DSM-5 Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
ELISA Enzyme-Linked Immunosorbent Assay
FAB Frontal Assessment Battery
FDR False Discovery Rate
FDG-PET Fluorodeoxyglucose Positron Emission Tomography
MCI Mild Cognitive Impairment
MMSE Mini-Mental State Examination
MoCA Montreal Cognitive Assessment
MRI Magnetic Resonance Imaging
NfL Neurofilament Light
OR Odds Ratio
PET Positron Emission Tomography
pTau Phosphorylated Tau
RAVLT Rey Auditory Verbal Learning Test
ROC Receiver Operating Characteristic
SD Standard Deviation
SNAP Suspected Non-Alzheimer’s Pathophysiology
tTau Total Tau
TMT-A/B Trail Making Test Parts A and B